Prevention of post-contrast kidney injury in patients with cancer

Emanuele Grassedonio, Lorena Incorvaia, Marco Guarneri, Fabio Guagnini, Massimo Midiri

Article Type

Review

Published

This article aims to review the literature on mechanisms of post-contrast acute kidney injury, risk factors and available strategies to control the risk in patients with cancer and to report the authors’ experience with managing post-contrast acute kidney injury risk in oncology.

Read more

Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences

Bernardo Rossini, Nicola Cecchi, Felice Clemente, Maria Rosaria De Paolis, Stefan Hohaus, Vanessa Innao, Mariano Lucignano, Roberto Massaiu, Giovanna Palumbo, Gian Matteo Rigolin, Francesca Gaia Rossi, Luisa Verga, Attilio Guarini

Article Type

Case Series

Published

This collection of clinical experiences focuses on patients on siltuximab therapy, particularly regarding the idiopathic multicentric Castleman disease (iMCD) diagnostic work-up and treatment administration in patients with complex disease entering differential diagnosis with Castleman disease or with concomitant diseases.

Read more

Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2– metastatic breast cancer: a prospective, monocentric study

Raffaella Palumbo, Erica Quaquarini, Giuseppe Saltalamacchia, Alberto Malovini, Pietro Lapidari, Barbara Tagliaferri, Ludovica Mollica, Cristina Maria Teragni, Chiara Barletta, Laura Deborah Locati, Federico Sottotetti

Article Type

Original Research

Published

The aim of this prospective study is to evaluate the efficacy and activity of the different oncological treatments in patients with HR+/HER– metastatic breast cancer progressing to CDK4/6i therapy in a real-world setting.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.